ZYMAXID

Země: Izrael

Jazyk: angličtina

Zdroj: Ministry of Health

Aktivní složka:

GATIFLOXACIN 0.5 %W/V

Dostupné s:

ALLERGAN ISRAEL LTD

ATC kód:

S01AX21

Léková forma:

OPHTHALMIC SOLUTION

Podání:

OCULAR

Výrobce:

ALLERGAN INC., USA

Terapeutické skupiny:

GATIFLOXACIN

Terapeutické indikace:

Zymaxid is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Aerobic Gram- Negative Bacteria : Haemophilus influenzae, Aerobic Gram-positive Bacteria: Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus mitis group*, Streptococcus oralis *, Streptococcus pneumoniae. Efficacy for this organisms was studied in fewer than 10 infections.

Datum autorizace:

2012-11-01